Zhihong Cai Selected Research

Zhihong Cai Research Topics

Disease

8	Neoplasm Metastasis (Metastasis) 02/2024 - 08/2018
7	Type 2 Diabetes Mellitus (MODY) 02/2024 - 01/2018
6	Neoplasms (Cancer) 04/2024 - 08/2018
4	Breast Neoplasms (Breast Cancer) 04/2024 - 09/2019
4	Rheumatoid Arthritis 01/2022 - 03/2016
3	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 01/2021
2	Body Weight (Weight, Body) 02/2024 - 01/2021
2	Lung Neoplasms (Lung Cancer) 02/2024 - 08/2019
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 12/2020
2	Pain (Aches) 11/2018 - 11/2018
1	Lymphatic Metastasis 04/2024
1	Obesity 02/2024
1	Abdominal Obesity 02/2024
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2023
1	Thyroid Neoplasms (Thyroid Cancer) 03/2023
1	Diarrhea 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	Disease Progression 12/2022
1	Exanthema (Rash) 12/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022
1	Infections 10/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Ascites 01/2022
1	Edema (Dropsy) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 09/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Proteinuria 01/2021
1	Migraine Disorders (Migraine) 11/2020
1	Insulin Resistance 10/2019
1	Hypoxia (Hypoxemia) 02/2019

Drug/Important Bio-Agent (IBA)

6	ErbB Receptors (EGF Receptor)IBA 04/2024 - 09/2019
4	Hormones (Hormone)IBA 04/2024 - 09/2019
3	dulaglutideIBA 01/2021 - 01/2018
3	Insulin (Novolin)FDA Link 10/2019 - 01/2018
2	Leucovorin (Folinic Acid)FDA Link 05/2024 - 01/2021
2	Fluorouracil (Carac)FDA LinkGeneric 05/2024 - 01/2021
2	Particulate MatterIBA 02/2024 - 08/2019
2	ixekizumabIBA 12/2023 - 12/2020
2	lenvatinibIBA 03/2023 - 09/2021
2	Sorafenib (BAY 43-9006)FDA Link 03/2023 - 09/2021
2	AlbuminsIBA 09/2021 - 01/2021
2	insulin degludecIBA 01/2020 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 08/2019 - 02/2019
2	Hypoglycemic Agents (Hypoglycemics)IBA 06/2018 - 01/2018
2	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 03/2016
2	baricitinibIBA 01/2018 - 03/2016
1	AntibodiesIBA 05/2024
1	Angiogenesis InhibitorsIBA 05/2024
1	Capecitabine (Xeloda)FDA Link 05/2024
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 05/2024
1	Progesterone FDA LinkGeneric 04/2024
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2024
1	Coal (Coals)IBA 02/2024
1	9,10-anthraquinoneIBA 01/2024
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 01/2024
1	Platelet-Derived Growth FactorIBA 01/2024
1	9-fluorenoneIBA 01/2024
1	7,12-benz(a)anthraquinoneIBA 01/2024
1	AngiopoietinsIBA 01/2024
1	1,8-naphthalenedicarboxylic acid anhydrideIBA 01/2024
1	Glutathione (Reduced Glutathione)IBA 01/2024
1	NAD (NADH)IBA 01/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2024
1	Interleukin-17 (Interleukin 17)IBA 12/2023
1	secukinumabIBA 12/2023
1	brodalumabIBA 12/2023
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 12/2023
1	Cardiovascular AgentsIBA 10/2023
1	vandetanib (ZD6474)IBA 03/2023
1	abemaciclibIBA 01/2023
1	palbociclibIBA 01/2023
1	Cyclin-Dependent Kinase 4IBA 01/2023
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2023
1	ibrutinibIBA 10/2022
1	Monoclonal AntibodiesIBA 01/2022
1	SDMIBA 01/2022
1	BilirubinIBA 09/2021
1	Bevacizumab (Avastin)FDA Link 01/2021
1	LipidsIBA 01/2021
1	LDL CholesterolIBA 01/2021
1	CholesterolIBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2021
1	Triglycerides (Triacylglycerol)IBA 01/2021
1	RamucirumabIBA 01/2021
1	afliberceptIBA 01/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2021
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2021
1	TEA Domain Transcription FactorsIBA 08/2019
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2019
1	Transcription Factors (Transcription Factor)IBA 08/2019

Therapy/Procedure

17	Therapeutics 05/2024 - 03/2016
3	Glycemic Control 02/2024 - 01/2018
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2022
1	Activities of Daily Living (ADL) 01/2021